researcher

Cassava Sciences has plummeted more than 40% after a Maryland grand jury indicted a Cassava Sciences (NASDAQ:SAVA) paid consultant and researcher on fraud charges. The charges against CUNY School of Medicine Professor Hoau-Yan Wang for falsifying data are regarding Cassava’s Alzheimer’s drug, simufilam, that Wang used to apply for NIHContinue Reading